{"id":1357,"date":"2026-05-27T15:12:00","date_gmt":"2026-05-27T12:12:00","guid":{"rendered":"https:\/\/lista-avocati.ro\/blog\/?p=1357"},"modified":"2026-05-28T11:16:17","modified_gmt":"2026-05-28T08:16:17","slug":"prin-art-i-din-ordinul-nr-873-2026-al-presedintelui-casei-nationale-de-asigurari-de-sanatate-publicat-in-monitorul-of","status":"publish","type":"post","link":"https:\/\/lista-avocati.ro\/blog\/prin-art-i-din-ordinul-nr-873-2026-al-presedintelui-casei-nationale-de-asigurari-de-sanatate-publicat-in-monitorul-of\/","title":{"rendered":"CNAS Introduce 18 Formulare Noi. Care Sunt Schimb\u0103rile"},"content":{"rendered":"<h3>CE S-A MODIFICAT<\/h3>\n<p>Prin <strong>art. I<\/strong> din Ordinul nr. 873\/2026 al pre\u0219edintelui Casei Na\u021bionale de Asigur\u0103ri de S\u0103n\u0103tate (publicat \u00een Monitorul Oficial nr. 443 din 26 mai 2026), se completeaz\u0103 anexa nr. 1 la Ordinul nr. 141\/2017, prin introducerea a <strong>18 noi pozi\u021bii<\/strong> (289\u2013306) \u00een tabelul formularelor specifice, \u00eenso\u021bite de <strong>18 noi formulare<\/strong> constituite ca Anexele nr. 1\u201318, conform <strong>art. I pct. 1 \u0219i 2<\/strong> \u0219i <strong>art. II<\/strong>.<\/p>\n<h3>CE \u00ceNSEAMN\u0102 PRACTIC<\/h3>\n<p>Medicamentele nou introduse \u00een sistemul de verificare a eligibilit\u0103\u021bii acoper\u0103 afec\u021biuni oncologice \u0219i hematologice grave:<\/p>\n<p>| Nr. crt. | Cod formular | DCI \/ Afec\u021biune |<br \/>\n|&#8211;|&#8211;|&#8211;|<br \/>\n| 289 | L04AJ03 | PEGCETACOPLANUM \u2014 hemoglobinurie paroxistic\u0103 nocturn\u0103 |<br \/>\n| 290 | L04AJ07 | CROVALIMABUM \u2014 hemoglobinurie paroxistic\u0103 nocturn\u0103 |<br \/>\n| 291 | L01FX12 | TAFASITAMABUM \u2014 limfom difuz cu celul\u0103 B mare (DLBCL) |<br \/>\n| 292 | L01XM02.2 | IVOSIDENIBUM \u2014 leucemie acut\u0103 mieloid\u0103 (LAM) |<br \/>\n| 293\u2013294 | L01EE02\/03 | COBIMETINIBUM+VEMURAFENIBUM \/ BINIMETINIBUM+ENCORAFENIBUM \u2014 melanom cutanat |<br \/>\n| 295 | L01EC03-FE01 | ENCORAFENIBUM + CETUXIMABUM \u2014 cancer colorectal |<br \/>\n| 296 | L01EM03 | ALPELISIB \u2014 cancer mamar |<br \/>\n| 297 | L01EN02 | PEMIGATINIBUM \u2014 colangiocarcinom |<br \/>\n| 298 | L01EX14 | ENTRECTINIBUM \u2014 tumori solide cu fuziune de gene NTRK |<br \/>\n| 299\u2013300 | L01EX18.1\/19 | AVAPRITINIBUM \/ RIPRETINIBUM \u2014 GIST |<br \/>\n| 301 | L01FX18 | AMIVANTAMABUM \u2014 cancer pulmonar f\u0103r\u0103 celule mici (NSCLC) |<br \/>\n| 302 | L01FX20 | TREMELIMUMABUM \u2014 carcinom hepatocelular |<br \/>\n| 303 | L01XK52 | NIRAPARIBUM + ABIRATERONUM \u2014 cancer de prostat\u0103 |<br \/>\n| 304 | L01XM02.1 | IVOSIDENIBUM \u2014 colangiocarcinom |<br \/>\n| 305 | V10XX05 | LUTETIUM (177 Lu) VIPIVOTIDE TETRAXETAN \u2014 cancer de prostat\u0103, mCRPC |<br \/>\n| 306 | C10AX18 | VOLANESORSENUM \u2014 sindromul chilomicronemiei familiale |<\/p>\n<p>Fiecare formular cuprinde: date generale (unitate medical\u0103, CAS\/nr. contract, cod paraf\u0103, date pacient) \u0219i date medicale cu criterii explicite de includere, excludere, continuare \u0219i \u00eentrerupere a tratamentului.<\/p>\n<h3>CINE E AFECTAT<\/h3>\n<li><strong>Unit\u0103\u021bile medicale<\/strong> contractate cu casele de asigur\u0103ri de s\u0103n\u0103tate, care prescriu medicamentele din pozi\u021biile 289\u2013306<\/li>\n<li><strong>Medicii prescriptori<\/strong> cu cod paraf\u0103, care r\u0103spund de realitatea \u0219i exactitatea complet\u0103rii formularelor<\/li>\n<li><strong>Asigura\u021bii<\/strong> cu afec\u021biunile acoperite de pozi\u021biile 289\u2013306, al c\u0103ror acces la tratament este condi\u021bionat de completarea formularelor de eligibilitate<\/li>\n<h3>CE TREBUIE F\u0102CUT<\/h3>\n<p>Conform <strong>art. I pct. 2<\/strong> \u0219i <strong>art. II<\/strong>:<\/p>\n<p>1. Utilizarea <strong>noilor formulare specifice<\/strong> (Anexele nr. 1\u201318) la orice evaluare de tip ini\u021biere, continuare sau \u00eentrerupere pentru medicamentele din pozi\u021biile 289\u2013306<br \/>\n2. Transmiterea formularelor completate \u00een <strong>platforma informatic\u0103 din asigur\u0103rile de s\u0103n\u0103tate<\/strong><br \/>\n3. Constituirea dosarului pacientului cu toate documentele anexate \u2014 evalu\u0103ri clinice, buletine, consim\u021b\u0103m\u00e2nt informat, declara\u021bie pe propria r\u0103spundere, confirmare \u00eenregistrare formular \u2014 ca document-surs\u0103 pentru audit\/control<\/p>\n<p><strong>Termen de aplicare:<\/strong> De la publicarea \u00een Monitorul Oficial nr. 443 din <strong>26 mai 2026<\/strong>, conform <strong>art. III<\/strong>.<\/p>\n<hr\/>\n<p><em>Analiz\u0103 generat\u0103 automat din Monitorul Oficial \u2014 50.ro AI Platform.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CE S-A MODIFICAT Prin art. I din Ordinul nr. 873\/2026 al pre\u0219edintelui Casei Na\u021bionale de Asigur\u0103ri de S\u0103n\u0103tate (publicat \u00een Monitorul Oficial nr. 443 din 26 mai 2026), se completeaz\u0103 anexa nr. 1 la Ordinul nr. 141\/2017, prin introducerea a 18 noi pozi\u021bii (289\u2013306) \u00een tabelul formularelor specifice, \u00eenso\u021bite de 18 noi formulare constituite ca &#8230; <a title=\"CNAS Introduce 18 Formulare Noi. Care Sunt Schimb\u0103rile\" class=\"read-more\" href=\"https:\/\/lista-avocati.ro\/blog\/prin-art-i-din-ordinul-nr-873-2026-al-presedintelui-casei-nationale-de-asigurari-de-sanatate-publicat-in-monitorul-of\/\" aria-label=\"Cite\u0219te mai multe despre CNAS Introduce 18 Formulare Noi. Care Sunt Schimb\u0103rile\">Cite\u0219te mai mult<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,16],"tags":[],"class_list":["post-1357","post","type-post","status-publish","format-standard","hentry","category-ghiduri-juridice","category-monitorul-oficial"],"_links":{"self":[{"href":"https:\/\/lista-avocati.ro\/blog\/wp-json\/wp\/v2\/posts\/1357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lista-avocati.ro\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lista-avocati.ro\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lista-avocati.ro\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/lista-avocati.ro\/blog\/wp-json\/wp\/v2\/comments?post=1357"}],"version-history":[{"count":3,"href":"https:\/\/lista-avocati.ro\/blog\/wp-json\/wp\/v2\/posts\/1357\/revisions"}],"predecessor-version":[{"id":1388,"href":"https:\/\/lista-avocati.ro\/blog\/wp-json\/wp\/v2\/posts\/1357\/revisions\/1388"}],"wp:attachment":[{"href":"https:\/\/lista-avocati.ro\/blog\/wp-json\/wp\/v2\/media?parent=1357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lista-avocati.ro\/blog\/wp-json\/wp\/v2\/categories?post=1357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lista-avocati.ro\/blog\/wp-json\/wp\/v2\/tags?post=1357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}